Carazolol: Difference between revisions
Content deleted Content added
Script assisted update of chemical identifiers from ChemSpider for the Chem/Drugbox validation project. |
No edit summary |
||
| Line 15: | Line 15: | ||
| PubChem=71739 |
| PubChem=71739 |
||
| DrugBank= |
| DrugBank= |
||
| C=18 | H=22 | N=2 | O= |
| C=18 | H=22 | N=2 | O=2 |
||
| molecular_weight = 298.38 |
| molecular_weight = 298.38 |
||
| bioavailability= |
| bioavailability= |
||
Revision as of 04:47, 12 February 2010
 | |
| Clinical data | |
|---|---|
| ATCvet code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.387 |
| Chemical and physical data | |
| Formula | C18H22N2O2 |
| Molar mass | 298.38 g·mol−1 |
| 3D model (JSmol) | |
| |
Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]
References
- ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
External links
- Carazolol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |